A Study of LM-364 as a Single Agent or in Combination With Anti-tumor Therapy in Patients With Advanced Solid Tumors
Clinical trial NCT07694765 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07694765
- Sponsor
- LaNova Medicines Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-15
- Primary completion
- 2028-12-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.